Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 27, 1931-1938, November 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levin, W.
Right arrow Articles by Conney, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levin, W.
Right arrow Articles by Conney, A. H.

Stimulatory Effect of Polycyclic Hydrocarbons and Aromatic Azo Derivatives on the Metabolism of 7,12-Dimethylbenz({alpha})anthracene1

W. Levin and A. H. Conney

The Wellcome Research Laboratories, Burroughs Wellcome & Co. (U.S.A.), Inc., Tuckahoe, New York 10707

Treatment of rats with certain polycyclic aromatic hydrocarbons and aromatic azo derivatives enhances severalfold the hepatic metabolism of 7, 12-dimethylbenz({alpha})anthracene (DMBA) to fluorescent metabolites. Studies with tritiated DMBA revealed that treatment of rats with 3-methylcholanthrene (MC) stimulates the hepatic metabolism of DMBA to 7-hydroxymethyl-12-methylbenz({alpha})anthracene (7-OHM-12-MBA), 12-hydroxymethyl-7-methylbenz({alpha})anthracene (12-OHM-7-MBA), and several unidentified polar metabolites. MC treatment also enhances the hepatic metabolism of monohydroxymethyl DMBA to highly polar unidentified compounds. The stimulatory effect of MC on the hepatic metabolism of DMBA and its monohydroxymethyl metabolites is paralleled by altered in vivo metabolism of DMBA. Treatment of rats with MC at 24 hours prior to DMBA-3H administration resulted in a markedly decreased concentration of tritiated hydrocarbon in the adrenal gland, mammary gland, and fat. More detailed examination of the adrenal gland and fat revealed that MC pretreatment decreased the concentrations of DMBA, 7-OHM-12-MBA, and 12-OHM-7-MBA in these tissues. The results obtained suggest that the induction of hepatic enzymes that metabolize DMBA and its monohydroxymethyl metabolites play an important role in decreasing the adrenal toxicity and carcinogenicity of DMBA in rats pretreated with polycyclic hydrocarbons and aromatic azo derivatives.

1 This study was supported by Research Contract No. PH 43-65-1066 from the Pharmacology-Toxicology Programs, NIGMS, NIH.

Received 2/ 1/67. Accepted 6/15/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1967 by the American Association for Cancer Research.